Skip to main content

Peer Review reports

From: Cost analysis of lurasidone for the treatment of schizophrenia in adolescents and adults within the United Kingdom

Original Submission
4 Jan 2022 Submitted Original manuscript
13 Mar 2022 Reviewed Reviewer Report
15 Jun 2022 Reviewed Reviewer Report - Itziar Oyagüez
11 Jul 2022 Author responded Author comments - Amy Dymond
Resubmission - Version 2
11 Jul 2022 Submitted Manuscript version 2
12 Jul 2022 Author responded Author comments - Amy Dymond
Resubmission - Version 3
12 Jul 2022 Submitted Manuscript version 3
30 Jul 2022 Reviewed Reviewer Report
1 Aug 2022 Reviewed Reviewer Report - Itziar Oyagüez
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
4 Aug 2022 Editorially accepted
25 Aug 2022 Article published 10.1186/s12913-022-08436-x

You can find further information about peer review here.

Back to article page